# Liberty reviews (2026): GLP-1 telehealth sellers | This GLP

The preparation is sourced from a 503B outsourcing facility, which is a different regulatory category from a retail compounding pharmacy.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/liberty
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 503B facility named as source

# Liberty review

The preparation is sourced from a 503B outsourcing facility, which is a different regulatory category from a retail compounding pharmacy.

## The verdict

Liberty prices compounded semaglutide at a flat $129 a month and compounded tirzepatide at a flat $219. Both are stated to come from a 503B outsourcing facility, after a clinician review. The facility type is the fact worth reading here.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

Dose pricing

Flat across doses

From

From $129/mo

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Not named

Liberty sells compounded semaglutide and compounded tirzepatide as weekly injections. The two figures read $129 and $219 a month. A three-month supply brings the semaglutide to $110 a month. Both rates are described as flat at every dose.

1.  ## Who writes the prescription, and what do they see?
    
    The prescription follows a clinician review rather than an automatic approval at checkout. That sequence is stated on the product pages for both molecules. What the review consists of, and whether it is live or asynchronous, is not published. The rate does not change with the outcome of the review.
    
    Treatment is arranged remotely and the injection is weekly. The tirzepatide is described as a dual GIP and GLP-1 agonist, which is what the molecule is. Liberty prices the two molecules $90 apart. Liberty describes no coaching or check-in program alongside the medication.
    
2.  ## What happens when the dose goes up?
    
    Both rates are stated as flat at every dose. A reader who reaches a maintenance dose in month four pays the same as in month one. Whether a dose change requires a further clinician review is not stated beside the price. The three-month supply is a prepay rather than a different rate.
    
3.  ## What the price includes
    
    $129 and $219 are month-to-month figures, and the three-month route drops the semaglutide to $110 and the tirzepatide to $186. The $90 step between molecules is the widest part of this seller's pricing. No state list is published, so a reader confirms coverage at intake. Nothing beside either figure was recorded as a separate charge.
    
4.  ## What it claims, and what it cites
    
    A 503B outsourcing facility registers with the FDA and makes products under current good manufacturing practice, which a 503A pharmacy does not. That is a real distinction, and it is not the same as approval: a compounded [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) from a 503B is still not an FDA-approved drug. The outcome trials used the approved products at label doses. Whether a 503B preparation matches them in content or purity is not measured here.
    

## Where it holds up, and where it does not

-   Strength: Pharmacy type named, not implied
-   Strength: Clinician review stated before prescribing
-   Strength: Rate flat at every dose
-   Limitation: No state list published
-   Limitation: Tirzepatide costs $90 more
-   Limitation: Facility name itself not published

## What the evidence says about this kind of treatment

The assessment above is about Liberty. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing.

Wrong for

A reader shopping the compounded market on price alone, since flat pricing and a named facility type are what the higher figure buys.

## The evidence behind what Liberty prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Liberty compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Harper Meds | A reader who wants a clinician, a prescription and the medication under one charge, with no term to commit to before reaching the published rate. |  |
| Apex MD | A reader who wants a month-to-month plan with no prepay commitment, and who is told what is in the vial before ordering. |  |
| EverSlim | A reader who wants one monthly charge covering the medication, the visit and the postage, without a prepay term attached to reach the rate. |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [SexyMD](https://thisglp.com/reviews/sexymd) [ShapeIn Rx](https://thisglp.com/reviews/shapein-rx) [Shapely](https://thisglp.com/reviews/shapely) [Signos](https://thisglp.com/reviews/signos) [Silhouette MD](https://thisglp.com/reviews/silhouette-md) [SkyRx](https://thisglp.com/reviews/skyrx)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

What is a 503B outsourcing facility?

It is a compounder registered with the FDA that makes products in batches under current good manufacturing practice. A 503A pharmacy compounds for individual prescriptions and is not held to that standard.

Does that make the medication FDA-approved?

No. A compounded preparation from a 503B facility is still not an FDA-approved drug and is not reviewed for safety or efficacy before it is dispensed.

Does the price rise with the dose?

Liberty states a flat rate at every dose on both molecules. A three-month supply lowers the semaglutide figure to $110 a month, billed $329 up front.

Is Liberty expensive compared with other GLP-1 telehealth sellers?

Liberty publishes a starting figure of $129/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Liberty below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
